Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan
· Delayed Price · Currency is TWD 22.95
+0.30 (1.32%)
Apr 29, 2026, 1:17 PM CST
Perfect Medical Industry Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 779.02 | 744.16 | 734.13 | 677.04 | 724.61 | Upgrade
|
| Revenue Growth (YoY) | 4.68% | 1.36% | 8.43% | -6.57% | -10.29% | Upgrade
|
| Cost of Revenue | 578.25 | 505.96 | 533.58 | 542.63 | 515.08 | Upgrade
|
| Gross Profit | 200.76 | 238.19 | 200.56 | 134.41 | 209.53 | Upgrade
|
| Selling, General & Admin | 133.61 | 135.78 | 134.78 | 123.61 | 145.44 | Upgrade
|
| Research & Development | 15.83 | 11.09 | 7.4 | 7.12 | 5.58 | Upgrade
|
| Operating Expenses | 149.35 | 146.95 | 142.2 | 130.75 | 151.28 | Upgrade
|
| Operating Income | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 | Upgrade
|
| Interest Expense | -6.83 | -3.72 | -4.37 | -4.46 | -2.96 | Upgrade
|
| Interest & Investment Income | 5.95 | 5.42 | 3.33 | 1.03 | 1.6 | Upgrade
|
| Currency Exchange Gain (Loss) | 13.12 | 13.42 | 7.34 | 13.18 | 3.93 | Upgrade
|
| Other Non Operating Income (Expenses) | 7.82 | 4.9 | 3.02 | 3.33 | 1.52 | Upgrade
|
| EBT Excluding Unusual Items | 71.47 | 111.26 | 67.67 | 16.73 | 62.33 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | 0.4 | 1.19 | 1.18 | 0.19 | Upgrade
|
| Asset Writedown | - | -4.28 | -14.61 | - | - | Upgrade
|
| Other Unusual Items | 0.08 | - | - | 0.06 | - | Upgrade
|
| Pretax Income | 71.53 | 107.38 | 54.25 | 17.98 | 62.52 | Upgrade
|
| Income Tax Expense | 17.29 | 18.26 | 14.16 | 3.71 | 23.75 | Upgrade
|
| Net Income | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 | Upgrade
|
| Net Income to Common | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 | Upgrade
|
| Net Income Growth | -39.13% | 122.31% | 180.93% | -63.20% | -61.49% | Upgrade
|
| Shares Outstanding (Basic) | 54 | 49 | 46 | 44 | 41 | Upgrade
|
| Shares Outstanding (Diluted) | 57 | 51 | 46 | 44 | 41 | Upgrade
|
| Shares Change (YoY) | 12.08% | 11.20% | 3.98% | 8.91% | -2.73% | Upgrade
|
| EPS (Basic) | 1.00 | 1.81 | 0.88 | 0.32 | 0.95 | Upgrade
|
| EPS (Diluted) | 0.95 | 1.74 | 0.87 | 0.32 | 0.95 | Upgrade
|
| EPS Growth | -45.40% | 100.00% | 171.88% | -66.32% | -60.44% | Upgrade
|
| Free Cash Flow | -88.46 | 46.56 | 85.17 | 52.87 | -98.89 | Upgrade
|
| Free Cash Flow Per Share | -1.54 | 0.91 | 1.85 | 1.20 | -2.43 | Upgrade
|
| Dividend Per Share | 0.200 | 1.500 | 0.700 | 0.370 | 0.316 | Upgrade
|
| Dividend Growth | -86.67% | 114.29% | 89.19% | 17.13% | -78.25% | Upgrade
|
| Gross Margin | 25.77% | 32.01% | 27.32% | 19.85% | 28.92% | Upgrade
|
| Operating Margin | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% | Upgrade
|
| Profit Margin | 6.96% | 11.98% | 5.46% | 2.11% | 5.35% | Upgrade
|
| Free Cash Flow Margin | -11.36% | 6.26% | 11.60% | 7.81% | -13.65% | Upgrade
|
| EBITDA | 113.78 | 141.78 | 108 | 51.54 | 100.5 | Upgrade
|
| EBITDA Margin | 14.61% | 19.05% | 14.71% | 7.61% | 13.87% | Upgrade
|
| D&A For EBITDA | 62.36 | 50.54 | 49.64 | 47.89 | 42.25 | Upgrade
|
| EBIT | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 | Upgrade
|
| EBIT Margin | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% | Upgrade
|
| Effective Tax Rate | 24.16% | 17.00% | 26.11% | 20.62% | 37.98% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.